Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2662 | 2181 | 43.9 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
1488 | 2 | CAMPTOTHECIN//TOPOISOMERASE I//SN 38 | 7627 |
2662 | 1 | TOPOISOMERASE II//DNA TOPOISOMERASE II//TOPOISOMERASE II ALPHA | 2181 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TOPOISOMERASE II | authKW | 1122843 | 11% | 34% | 238 |
2 | DNA TOPOISOMERASE II | authKW | 436323 | 3% | 47% | 67 |
3 | TOPOISOMERASE II ALPHA | authKW | 317345 | 3% | 31% | 73 |
4 | ICRF 193 | authKW | 291563 | 1% | 77% | 27 |
5 | TOPOISOMERASE II BETA | authKW | 249965 | 1% | 71% | 25 |
6 | TOPOISOMERASE | authKW | 211241 | 5% | 14% | 105 |
7 | CATALYTIC INHIBITOR | authKW | 146295 | 1% | 58% | 18 |
8 | DNA TOPOISOMERASE II ALPHA | authKW | 130200 | 1% | 47% | 20 |
9 | F 11782 | authKW | 125990 | 0% | 100% | 9 |
10 | BISDIOXOPIPERAZINE | authKW | 124508 | 1% | 68% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 6127 | 28% | 0% | 621 |
2 | Biochemistry & Molecular Biology | 4320 | 39% | 0% | 841 |
3 | Toxicology | 1166 | 8% | 0% | 166 |
4 | Pharmacology & Pharmacy | 1020 | 15% | 0% | 324 |
5 | Cell Biology | 970 | 13% | 0% | 274 |
6 | Genetics & Heredity | 688 | 9% | 0% | 190 |
7 | Biophysics | 375 | 6% | 0% | 127 |
8 | Chemistry, Medicinal | 274 | 4% | 0% | 89 |
9 | Hematology | 85 | 3% | 0% | 60 |
10 | Pathology | 55 | 2% | 0% | 47 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEMATOL ONCOL DEV THER EUT SECT | 41997 | 0% | 100% | 3 |
2 | INTER ONCOL | 37328 | 0% | 67% | 4 |
3 | ENZYMOL ACIDES NUCLCNRSURA 2225 | 27998 | 0% | 100% | 2 |
4 | MED CELLULAR MOL SCI MOL GENET GRP | 27998 | 0% | 100% | 2 |
5 | MED HEMATOL ONCOL | 26858 | 3% | 3% | 56 |
6 | MED MYCOL SHOWA KU | 21866 | 0% | 31% | 5 |
7 | EXPT CANCEROL 1 | 18664 | 0% | 67% | 2 |
8 | BIOL PHARMACOL DNA TOPOISOMERASES | 17995 | 0% | 43% | 3 |
9 | REG CANC TREATMENT SERV | 17995 | 0% | 43% | 3 |
10 | 13TH FLOOR | 13999 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER RESEARCH | 8349 | 7% | 0% | 154 |
2 | BIOCHEMICAL PHARMACOLOGY | 6157 | 4% | 0% | 91 |
3 | MOLECULAR PHARMACOLOGY | 4742 | 3% | 1% | 58 |
4 | ANTI-CANCER DRUG DESIGN | 3748 | 1% | 2% | 13 |
5 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2988 | 2% | 1% | 40 |
6 | BIOCHEMISTRY | 2969 | 5% | 0% | 109 |
7 | MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | 2769 | 1% | 1% | 28 |
8 | MUTATION RESEARCH | 2176 | 2% | 0% | 36 |
9 | JOURNAL OF BIOLOGICAL CHEMISTRY | 2151 | 7% | 0% | 160 |
10 | BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 2025 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TOPOISOMERASE II | 1122843 | 11% | 34% | 238 | Search TOPOISOMERASE+II | Search TOPOISOMERASE+II |
2 | DNA TOPOISOMERASE II | 436323 | 3% | 47% | 67 | Search DNA+TOPOISOMERASE+II | Search DNA+TOPOISOMERASE+II |
3 | TOPOISOMERASE II ALPHA | 317345 | 3% | 31% | 73 | Search TOPOISOMERASE+II+ALPHA | Search TOPOISOMERASE+II+ALPHA |
4 | ICRF 193 | 291563 | 1% | 77% | 27 | Search ICRF+193 | Search ICRF+193 |
5 | TOPOISOMERASE II BETA | 249965 | 1% | 71% | 25 | Search TOPOISOMERASE+II+BETA | Search TOPOISOMERASE+II+BETA |
6 | TOPOISOMERASE | 211241 | 5% | 14% | 105 | Search TOPOISOMERASE | Search TOPOISOMERASE |
7 | CATALYTIC INHIBITOR | 146295 | 1% | 58% | 18 | Search CATALYTIC+INHIBITOR | Search CATALYTIC+INHIBITOR |
8 | DNA TOPOISOMERASE II ALPHA | 130200 | 1% | 47% | 20 | Search DNA+TOPOISOMERASE+II+ALPHA | Search DNA+TOPOISOMERASE+II+ALPHA |
9 | F 11782 | 125990 | 0% | 100% | 9 | Search F+11782 | Search F+11782 |
10 | BISDIOXOPIPERAZINE | 124508 | 1% | 68% | 13 | Search BISDIOXOPIPERAZINE | Search BISDIOXOPIPERAZINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FORTUNE, JM , OSHEROFF, N , (2000) TOPOISOMERASE II AS A TARGET FOR ANTICANCER DRUGS: WHEN ENZYMES STOP BEING NICE.PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 64. VOL. 64. ISSUE . P. 221 -253 | 181 | 76% | 229 |
2 | BAKSHI, RP , GALANDE, S , MUNIYAPPA, K , (2001) FUNCTIONAL AND REGULATORY CHARACTERISTICS OF EUKARYOTIC TYPE II DNA TOPOISOMERASE.CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 36. ISSUE 1. P. 1 -37 | 198 | 76% | 40 |
3 | BURDEN, DA , OSHEROFF, N , (1998) MECHANISM OF ACTION OF EUKARYOTIC TOPOISOMERASE II AND DRUGS TARGETED TO THE ENZYME.BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION. VOL. 1400. ISSUE 1-3. P. 139 -154 | 126 | 86% | 366 |
4 | WANG, JC , (1996) DNA TOPOISOMERASES.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 65. ISSUE . P. 635-692 | 177 | 36% | 1741 |
5 | CHIKAMORI, K , GROZAV, AG , KOZUKI, T , GRABOWSKI, D , GANAPATHI, R , GANAPATHI, MK , (2010) DNA TOPOISOMERASE II ENZYMES AS MOLECULAR TARGETS FOR CANCER CHEMOTHERAPY.CURRENT CANCER DRUG TARGETS. VOL. 10. ISSUE 7. P. 758-771 | 132 | 69% | 42 |
6 | WILSTERMANN, AM , OSHEROOF, N , (2003) STABILIZATION OF EUKARYOTIC TOPOISOMERASE II-DNA CLEAVAGE COMPLEXES.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 3. ISSUE 3. P. 321 -338 | 134 | 72% | 117 |
7 | CORBETT, AH , OSHEROFF, N , (1993) WHEN GOOD ENZYMES GO BAD - CONVERSION OF TOPOISOMERASE-II TO A CELLULAR TOXIN BY ANTINEOPLASTIC DRUGS.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 6. ISSUE 5. P. 585-597 | 162 | 74% | 158 |
8 | DEWEESE, JE , OSHEROFF, N , (2009) THE DNA CLEAVAGE REACTION OF TOPOISOMERASE II: WOLF IN SHEEP'S CLOTHING.NUCLEIC ACIDS RESEARCH. VOL. 37. ISSUE 3. P. 738 -748 | 85 | 62% | 123 |
9 | MCCLENDON, AK , OSHEROFF, N , (2007) DNA TOPOISOMERASE II, GENOTOXICITY, AND CANCER.MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. VOL. 623. ISSUE 1-2. P. 83 -97 | 89 | 56% | 140 |
10 | NITISS, JL , (2009) TARGETING DNA TOPOISOMERASE II IN CANCER CHEMOTHERAPY.NATURE REVIEWS CANCER. VOL. 9. ISSUE 5. P. 338 -350 | 68 | 44% | 489 |
Classes with closest relation at Level 1 |